日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer

STRATEGIC-1：一项针对不可切除的 RAS/BRAF 野生型转移性结直肠癌的多线、随机、开放标签的 GERCOR-PRODIGE-39 III 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-026-02639-y
Chibaudel, Benoist; Dourthe, Louis-Marie; André, Thierry; Henriques, Julie; Bourgeois, Vincent; Etienne, Pierre-Luc; Desramé, Jérôme; Carola, Elisabeth; Dupuis, Olivier; Baba-Hamed, Nabil; Auby, Dominique; Louvet, Christophe; Maillard, Emmanuel; Romano, Olivier; Tournigand, Christophe; Garcia-Larnicol, Marie-Line; Shacham-Shmueli, Einat; Bird, Brian Healey; Ghiringhelli, François; de Gramont, Aimery
肿瘤
肠癌
肿瘤免疫
PROD
BRAF
IGE
RAS
发表日期：2026
文献求助 收藏

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial

舒尼替尼作为晚期肝内胆管癌二线治疗：SUN-CK GERCOR II期试验结果

期刊:Liver International
影响因子:5.2
doi:10.1111/liv.70196
Gros, Louis; Bouattour, Mohamed; Dumont, Clément; Dahan, Laëtitia; Malka, David; Tijeras-Raballand, Annemilaï; De Gramont, Armand; Ronot, Maxime; Dreyer, Chantal; Neuzillet, Cindy; Bourget, Philippe; Hadengue, Alexandra; Roldan, Nelly; Garcia-Larnicol, Marie-Line; Chibaudel, Benoist; Raymond, Eric; Faivre, Sandrine
肿瘤
胆管癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study

通过 mTOR 抑制和化疗作为局部晚期头颈部鳞状细胞癌的诱导疗法来靶向肿瘤微环境：CAPRA 研究

期刊:Cancers
影响因子:
doi:10.3390/cancers14184509
Diane Evrard, Clément Dumont, Michel Gatineau, Jean-Pierre Delord, Jérôme Fayette, Chantal Dreyer, Annemilaï Tijeras-Raballand, Armand de Gramont, Jean-François Delattre, Muriel Granier, Nasredine Aissat, Marie-Line Garcia-Larnicol, Khemaies Slimane, Benoist Chibaudel, Eric Raymond, Christophe Le To
肿瘤
头颈癌
肿瘤细胞
mTOR
发表日期：2022
文献求助 收藏

1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management

1673MO GCO-002 CACOVID-19队列：一项法国全国多中心研究，探讨COVID-19感染癌症患者及其对癌症治疗的影响

期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2021.01.069
Montopoli, M; Zorzi, M; Cocetta, V; Prayer-Galetti, T; Guzzinati, S; Bovo, E; Rugge, M; Calcinotto, A; Lièvre, A; Turpin, A; Ray-Coquard, IL; Le Malicot, K; Thariat, J; Ahle, G; Mathieu, R; Sebbagh, V; Debieuvre, D; Canellas, A; Garcia-Larnicol, M-L; Colle, R; Hardy-Bessard, A-C; Mansi, L; Bourhis, J; Gorphe, P; Ursu, R; IDBAIH Ahmed, A; Zalcman, G; Bouche, O
炎症/感染
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study

RECIST 和 iRECIST 标准用于评估纳武利尤单抗联合伊匹木单抗治疗微卫星不稳定性高/错配修复缺陷型转移性结直肠癌患者的疗效：GERCOR NIPICOL II 期研究

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2020-001499
Cohen, Romain; Bennouna, Jaafar; Meurisse, Aurélia; Tournigand, Christophe; De La Fouchardière, Christelle; Tougeron, David; Borg, Christophe; Mazard, Thibault; Chibaudel, Benoist; Garcia-Larnicol, Marie-Line; Svrcek, Magali; Vernerey, Dewi; Menu, Yves; André, Thierry
肿瘤
肠癌
肿瘤免疫
COL
发表日期：2020
文献求助 收藏

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial

FOLFOX4方案与序贯剂量密集型FOLFOX7方案联合FOLFIRI方案治疗可切除转移性结直肠癌患者，其健康相关生活质量评分恶化时间的比较：MIROX随机III期试验

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0157067
Hamidou, Zeinab; Chibaudel, Benoist; Hebbar, Mohamed; Hug de Larauze, Marine; André, Thierry; Louvet, Christophe; Brusquant, David; Garcia-Larnicol, Marie-Line; de Gramont, Aimery; Bonnetain, Franck
肿瘤
肠癌
肿瘤免疫
发表日期：2016
文献求助 收藏